세계 동위원소 시장 : 유형별, 용도별 - 기회 분석과 산업 예측(2024-2033년)

The global isotopes market was valued at $11.3 billion in 2023, and is projected to reach $25.8 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Isotopes can be classified into stable and radioactive (unstable) isotopes. Stable isotopes do not change over time and are not radioactive, while radioactive isotopes, or radionuclides, decay over time into other elements, emitting radiation in the process. The stability or radioactivity of an isotope influences its application in various fields, including medicine, industry, and research. Radioactive isotopes are used in various imaging techniques. For instance, Technetium-99m is widely used in single photon emission computed tomography (SPECT) scans due to its ideal properties for imaging, such as its short half-life and the gamma rays it emits. This isotope helps in visualizing organs, bones, and other tissues, aiding in the diagnosis of conditions like cancer, heart disease, and bone disorders.

Radioisotopes play a important role in the medical treatment. For instance, Iodine-131 is used in the treatment of thyroid cancer and hyperthyroidism. This isotope targets thyroid cells and emits radiation to destroy cancerous cells or reduce the function of an overactive thyroid. Similarly, strontium-89 and samarium-153 are used to treat bone pain associated with metastatic cancer by targeting bone lesions. In cancer treatment, radioactive isotopes such as cobalt-60 are used in external beam radiotherapy. Cobalt-60 emits gamma rays that can penetrate the body and kill cancer cells, while minimizing damage to surrounding healthy tissue.

In industrial radiography, isotopes like iridium-192 and cobalt-60 are used to inspect the integrity of structures and components. These isotopes emit gamma rays that pass through materials, and the resulting images reveal internal flaws such as cracks or corrosion, which are crucial for ensuring the safety and reliability of structures like pipelines and welds. Isotopes serve as tracers in studies of industrial processes. For instance, Carbon-14 and deuterium (a stable isotope of hydrogen) are used to trace chemical reactions and processes, allowing scientists to study reaction mechanisms, flow patterns, and material distribution. This helps optimize processes in industries such as petrochemicals and pharmaceuticals.

Isotopes help in studying water sources and movement. For example, tritium (a radioactive isotope of hydrogen) is used to trace groundwater movement and assess water age. Stable isotopes of hydrogen and oxygen are also used to analyze the origins and pathways of water bodies, aiding in water resource management and pollution studies. Stable isotopes such as carbon-13 and nitrogen-15 are used to study metabolic processes, food webs, and nutrient cycling in biological systems. Isotopic labeling helps trace the movement of elements through organisms and ecosystems, providing valuable information on biological functions and interactions

The isotopes market is segmented into type, end-use industry, and region. On the basis of type, the market is classified into stable and unstable. On the basis of application, the market is classified into medical, industrial, agricultural, and others. Based on region the market is divided into North America, Europe, Asia-Pacific, and LAMEA.

On the basis of type, unstable is the fastest-growing segment in the market representing the CAGR of 9.0% during the forecast period. Unstable isotopes, also known as radioactive isotopes or radioisotopes, have diverse and critical applications across numerous industries, despite their inherent instability. In the medical field, unstable isotopes are essential for diagnostic imaging and treatment. For example, technetium-99m, a gamma-emitting isotope, is widely used in nuclear medicine for imaging bones, organs, and tissues due to its ability to highlight physiological processes. Radioactive iodine (I-131) is also extensively used to treat thyroid conditions, including hyperthyroidism and certain types of cancer, as it can selectively target thyroid cells. Additionally, positron-emitting isotopes like fluorine-18 are used in positron emission tomography (PET) scans to visualize metabolic activity in tissues, aiding in early diagnosis of diseases such as cancer.

Based on region Asia-Pacific dominated and fastest growing segment in the market representing the CAGR of 9.0% during the forecast period. In the Asia-Pacific region, isotopes are widely used across various applications, products, and industries, significantly impacting medical, industrial, agricultural, and environmental sectors. In the medical field, isotopes like Technetium-99m are heavily utilized for diagnostic imaging and cancer treatment in countries such as Japan, South Korea, and China. Radiotherapy, nuclear imaging, and PET scans are critical healthcare services that benefit from these isotopes, helping identify, monitor, and treat conditions with high precision. Iodine-131 and Cobalt-60 are other common isotopes used in cancer treatments and radiotherapy, enabling hospitals and medical centers across Asia-Pacific to offer more advanced medical interventions.

Innovations in nuclear medicine technologies are expected to drive the growth of the isotopes market during the forecast period. Advancements in nuclear medicine have spurred demand for specialized isotopes due to innovations in radiopharmaceuticals and imaging technologies. This field uses radioactive isotopes for diagnosing and treating diseases, with imaging methods like PET and SPECT being key. Recent breakthroughs have led to the development of more effective radiopharmaceuticals. In February 2022, the society of nuclear medicine and molecular Imaging (SNMMI) launched an initiative to certify nuclear medicine facilities as Centers of Excellence in Radiopharmaceutical Therapy. This program sets high standards for regulatory compliance, staff training, qualifications, and performance to ensure the best outcomes for patients undergoing radiopharmaceutical therapy.

Limited availability of raw materials is expected to restraint the growth of the isotopes market during the forecast period. The availability of raw materials required for isotope production is a significant constraint in the isotopes market. Many isotopes are produced from rare or less abundant materials, and the supply of these raw materials can be limited. This scarcity can lead to increased costs for both the production of isotopes and the end products that utilize them. For example, certain isotopes used in medical imaging or industrial applications are derived from specific elements or minerals that are not widely distributed.

The key players operating in the isotopes market include 3M, Isotope JSC, Cambridge Isotope Laboratories, Inc, Center of Molecular Research (CMR), Urenco, National High Technology Centre of Georgia, Linde plc, Marshall Isotopes Ltd, Eckert & Ziegler, and Laurentis Energy Partners Inc.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the isotopes market analysis from 2023 to 2033 to identify the prevailing isotopes market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the isotopes market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global isotopes market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Analysis of raw material in a product (by %)
• End user preferences and pain points
• Investment Opportunities
• Upcoming/New Entrant by Regions
• Technology Trend Analysis
• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Patient/epidemiology data at country, region, global level
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• List of customers/consumers/raw material suppliers- value chain analysis
• SWOT Analysis
• Volume Market Size and Forecast

Key Market Segments

By Type

• Stable
• Unstable

By Application

• Others
• Medical
• Industrial
• Agricultural

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• 3M
• Cambridge Isotope Laboratories, Inc.
• Center of Molecular Research (CMR)
• Eckert & Ziegler
• Isotope JSC
• Laurentis Energy Partners Inc.
• Linde PLC
• Marshall Isotopes Ltd.
• Nordion (Canada) Inc.
• Urenco

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Moderate bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderatre threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. Moderate bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Innovations in nuclear medicine technologies
    • 3.4.1.2. Increase in demand for industrial radiography
  • 3.4.2. Restraints
    • 3.4.2.1. High production costs of isotopes
  • 3.4.3. Opportunities
    • 3.4.3.1. Increase in demand for diagnostic imaging
• 3.5. Patent Analysis

CHAPTER 4: ISOTOPES MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Stable
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Unstable
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: ISOTOPES MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Medical
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Industrial
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Agricultural
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Others
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: ISOTOPES MARKET, BY REGION

• 6.1. Overview
  • 6.1.1. Market size and forecast By Region
• 6.2. North America
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by Type
  • 6.2.3. Market size and forecast, by Application
  • 6.2.4. Market size and forecast, by country
    • 6.2.4.1. U.S.
    • 6.2.4.1.1. Market size and forecast, by Type
    • 6.2.4.1.2. Market size and forecast, by Application
    • 6.2.4.2. Canada
    • 6.2.4.2.1. Market size and forecast, by Type
    • 6.2.4.2.2. Market size and forecast, by Application
    • 6.2.4.3. Mexico
    • 6.2.4.3.1. Market size and forecast, by Type
    • 6.2.4.3.2. Market size and forecast, by Application
• 6.3. Europe
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by Type
  • 6.3.3. Market size and forecast, by Application
  • 6.3.4. Market size and forecast, by country
    • 6.3.4.1. Germany
    • 6.3.4.1.1. Market size and forecast, by Type
    • 6.3.4.1.2. Market size and forecast, by Application
    • 6.3.4.2. France
    • 6.3.4.2.1. Market size and forecast, by Type
    • 6.3.4.2.2. Market size and forecast, by Application
    • 6.3.4.3. UK
    • 6.3.4.3.1. Market size and forecast, by Type
    • 6.3.4.3.2. Market size and forecast, by Application
    • 6.3.4.4. Spain
    • 6.3.4.4.1. Market size and forecast, by Type
    • 6.3.4.4.2. Market size and forecast, by Application
    • 6.3.4.5. Italy
    • 6.3.4.5.1. Market size and forecast, by Type
    • 6.3.4.5.2. Market size and forecast, by Application
    • 6.3.4.6. Rest of Europe
    • 6.3.4.6.1. Market size and forecast, by Type
    • 6.3.4.6.2. Market size and forecast, by Application
• 6.4. Asia-Pacific
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by Type
  • 6.4.3. Market size and forecast, by Application
  • 6.4.4. Market size and forecast, by country
    • 6.4.4.1. China
    • 6.4.4.1.1. Market size and forecast, by Type
    • 6.4.4.1.2. Market size and forecast, by Application
    • 6.4.4.2. India
    • 6.4.4.2.1. Market size and forecast, by Type
    • 6.4.4.2.2. Market size and forecast, by Application
    • 6.4.4.3. Japan
    • 6.4.4.3.1. Market size and forecast, by Type
    • 6.4.4.3.2. Market size and forecast, by Application
    • 6.4.4.4. South Korea
    • 6.4.4.4.1. Market size and forecast, by Type
    • 6.4.4.4.2. Market size and forecast, by Application
    • 6.4.4.5. Australia
    • 6.4.4.5.1. Market size and forecast, by Type
    • 6.4.4.5.2. Market size and forecast, by Application
    • 6.4.4.6. Rest of Asia-Pacific
    • 6.4.4.6.1. Market size and forecast, by Type
    • 6.4.4.6.2. Market size and forecast, by Application
• 6.5. LAMEA
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by Type
  • 6.5.3. Market size and forecast, by Application
  • 6.5.4. Market size and forecast, by country
    • 6.5.4.1. Brazil
    • 6.5.4.1.1. Market size and forecast, by Type
    • 6.5.4.1.2. Market size and forecast, by Application
    • 6.5.4.2. South Africa
    • 6.5.4.2.1. Market size and forecast, by Type
    • 6.5.4.2.2. Market size and forecast, by Application
    • 6.5.4.3. Saudi Arabia
    • 6.5.4.3.1. Market size and forecast, by Type
    • 6.5.4.3.2. Market size and forecast, by Application
    • 6.5.4.4. Rest of LAMEA
    • 6.5.4.4.1. Market size and forecast, by Type
    • 6.5.4.4.2. Market size and forecast, by Application

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top winning strategies
• 7.3. Product mapping of top 10 player
• 7.4. Competitive dashboard
• 7.5. Competitive heatmap
• 7.6. Top player positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. 3M
  • 8.1.1. Company overview
  • 8.1.2. Key executives
  • 8.1.3. Company snapshot
  • 8.1.4. Operating business segments
  • 8.1.5. Product portfolio
  • 8.1.6. Business performance
• 8.2. Isotope JSC
  • 8.2.1. Company overview
  • 8.2.2. Key executives
  • 8.2.3. Company snapshot
  • 8.2.4. Operating business segments
  • 8.2.5. Product portfolio
• 8.3. Cambridge Isotope Laboratories, Inc.
  • 8.3.1. Company overview
  • 8.3.2. Key executives
  • 8.3.3. Company snapshot
  • 8.3.4. Operating business segments
  • 8.3.5. Product portfolio
• 8.4. Center of Molecular Research (CMR)
  • 8.4.1. Company overview
  • 8.4.2. Key executives
  • 8.4.3. Company snapshot
  • 8.4.4. Operating business segments
  • 8.4.5. Product portfolio
• 8.5. Urenco
  • 8.5.1. Company overview
  • 8.5.2. Key executives
  • 8.5.3. Company snapshot
  • 8.5.4. Operating business segments
  • 8.5.5. Product portfolio
  • 8.5.6. Business performance
  • 8.5.7. Key strategic moves and developments
• 8.6. Linde PLC
  • 8.6.1. Company overview
  • 8.6.2. Key executives
  • 8.6.3. Company snapshot
  • 8.6.4. Operating business segments
  • 8.6.5. Product portfolio
  • 8.6.6. Business performance
• 8.7. Marshall Isotopes Ltd.
  • 8.7.1. Company overview
  • 8.7.2. Key executives
  • 8.7.3. Company snapshot
  • 8.7.4. Operating business segments
  • 8.7.5. Product portfolio
• 8.8. Eckert & Ziegler
  • 8.8.1. Company overview
  • 8.8.2. Key executives
  • 8.8.3. Company snapshot
  • 8.8.4. Operating business segments
  • 8.8.5. Product portfolio
  • 8.8.6. Business performance
• 8.9. Laurentis Energy Partners Inc.
  • 8.9.1. Company overview
  • 8.9.2. Key executives
  • 8.9.3. Company snapshot
  • 8.9.4. Operating business segments
  • 8.9.5. Product portfolio
• 8.10. Nordion (Canada) Inc.
  • 8.10.1. Company overview
  • 8.10.2. Key executives
  • 8.10.3. Company snapshot
  • 8.10.4. Operating business segments
  • 8.10.5. Product portfolio